Hao Cai

5.1k total citations · 2 hit papers
120 papers, 3.6k citations indexed

About

Hao Cai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hao Cai has authored 120 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Hao Cai's work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (13 papers) and Cancer-related molecular mechanisms research (10 papers). Hao Cai is often cited by papers focused on Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (13 papers) and Cancer-related molecular mechanisms research (10 papers). Hao Cai collaborates with scholars based in China, United States and Hong Kong. Hao Cai's co-authors include Kui Luo, Zhongwei Gu, Hu Zhang, Qiyong Gong, Long Ren, Xuelei Ma, Zhilin Li, Hui‐Chuan Sun, Xiaoqin Lai and Tilman Wolf and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Hao Cai

113 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

2022 487 citations Long Ren, Hao Cai et al. profile →
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy

2024 47 citations Zhilin Li, Qianfeng Zhang et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hao Cai China	30	1.4k	1.1k	672	666	656	120	3.6k
Guanbin Song China	38	1.9k 1.4×	1.1k 1.0×	461 0.7×	681 1.0×	342 0.5×	144	4.9k
Yongbing Chen China	33	1.4k 1.0×	682 0.6×	432 0.6×	673 1.0×	319 0.5×	176	3.4k
Shiladitya Sengupta United States	32	1.6k 1.1×	1.5k 1.4×	1.1k 1.6×	839 1.3×	508 0.8×	80	4.0k
Lei Yu China	32	1.1k 0.8×	663 0.6×	495 0.7×	982 1.5×	460 0.7×	104	2.7k
Maoyu Li China	31	2.0k 1.4×	724 0.7×	478 0.7×	651 1.0×	309 0.5×	111	3.9k
Shuo Wang China	35	2.0k 1.4×	713 0.6×	189 0.3×	915 1.4×	834 1.3×	141	3.8k
Masahiro Yasunaga Japan	34	1.6k 1.1×	566 0.5×	531 0.8×	970 1.5×	268 0.4×	169	3.5k
Jian Ni China	33	1.2k 0.9×	883 0.8×	571 0.8×	507 0.8×	259 0.4×	98	3.2k
Byeong‐Cheol Ahn South Korea	42	2.8k 2.0×	1.0k 0.9×	335 0.5×	912 1.4×	823 1.3×	274	6.6k
Hui Lin China	33	2.0k 1.4×	884 0.8×	167 0.2×	513 0.8×	291 0.4×	141	3.9k

Countries citing papers authored by Hao Cai

Since Specialization

Citations

This map shows the geographic impact of Hao Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Cai more than expected).

Fields of papers citing papers by Hao Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Cai. The network helps show where Hao Cai may publish in the future.

Co-authorship network of co-authors of Hao Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Cai. A scholar is included among the top collaborators of Hao Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Cai. Hao Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Zhihao, Xiaosong Lin, Qi Ouyang, et al.. (2025). A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults. Vaccines. 13(3). 262–262. 1 indexed citations

Tian, Tian, Mingxiong He, Xiaofang Liu, et al.. (2025). Exploring the influence of pre-analytical variables on gene expression measurements and relative expression orderings in cancer research. Scientific Reports. 15(1). 4489–4489.

Deng, Min, Rongce Zhao, Hao Zou, et al.. (2025). Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma. British Journal of Cancer. 132(4). 371–383. 2 indexed citations

Chen, Chao, Zhe Zhuang, Hao Cai, et al.. (2024). Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA. Journal of Cellular and Molecular Medicine. 28(14). e18576–e18576. 5 indexed citations

Cai, Xiaoyu, Huo‐Liang Zheng, Hao Cai, et al.. (2024). Investigating the causal links between inflammatory cytokines and scoliosis through bidirectional Mendelian randomization analysis. JOR Spine. 7(4). e70019–e70019.

Deng, Min, Chong Zhong, Dong Li, et al.. (2024). Hepatic arterial infusion chemotherapy-based conversion hepatectomy in responders versus nonresponders with hepatocellular carcinoma: a multicenter cohort study. International Journal of Surgery. 111(1). 135–145. 6 indexed citations

Li, Zhilin, Qianfeng Zhang, Zhiqian Li, et al.. (2024). Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy. Acta Pharmaceutica Sinica B. 14(5). 2194–2209. 47 indexed citations breakdown →

Cai, Hao, et al.. (2023). Investigation on strong vertical permeability and micro-pore characteristics of Jinan red clay using X-ray micro-tomography. Environmental Earth Sciences. 82(5). 3 indexed citations

Zhang, Junli, Zhifeng Cheng, Zhoujun Yang, et al.. (2023). Experimental and numerical modeling of plasma start-up assisted by electron drift injection on J-TEXT. Nuclear Fusion. 63(6). 66012–66012.

10.

Huang, Miao, Hao Cai, Yichi Zhang, et al.. (2022). C‐C motif chemokine ligand 5 confines liver regeneration by down‐regulating reparative macrophage‐derived hepatocyte growth factor in a forkhead box O 3a–dependent manner. Hepatology. 76(6). 1706–1722. 31 indexed citations

11.

Song, Kai, Hao Cai, Hailong Zheng, et al.. (2021). Multilevel prioritization of gene regulators associated with consensus molecular subtypes of colorectal cancer. Briefings in Bioinformatics. 22(5). 5 indexed citations

12.

Zhou, Qiang, Hao Cai, Minghao Xu, et al.. (2020). Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?. Hepatobiliary & pancreatic diseases international. 20(1). 13–20. 11 indexed citations

13.

Ao, Jian‐Yang, Xiao‐Dong Zhu, Zong‐Tao Chai, et al.. (2017). Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 16(8). 1544–1554. 153 indexed citations

14.

Chen, Shuying, De-Ning Ma, Jingjun Zhang, et al.. (2017). MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma. Journal of Cancer. 8(4). 617–625. 29 indexed citations

15.

Guo, Chunhua, Ling Sun, Hao Cai, et al.. (2017). Gadolinium-Labeled Biodegradable Dendron–Hyaluronic Acid Hybrid and Its Subsequent Application as a Safe and Efficient Magnetic Resonance Imaging Contrast Agent. ACS Applied Materials & Interfaces. 9(28). 23508–23519. 65 indexed citations

16.

Zhu, Bo, Quanze He, Jingjing Xiang, et al.. (2017). Quantitative Phosphoproteomic Analysis Reveals Key Mechanisms of Cellular Proliferation in Liver Cancer Cells. Scientific Reports. 7(1). 10908–10908. 8 indexed citations

17.

Cai, Hao & Tilman Wolf. (2015). On 2-way neighbor discovery in wireless networks with directional antennas. 702–710. 29 indexed citations

18.

Zuo, Jie, et al.. (2015). An inhibitory role of NEK6 in TGFβ/Smad signaling pathway. BMB Reports. 48(8). 473–478. 23 indexed citations

19.

Ao, Lu, Haidan Yan, Tingting Zheng, et al.. (2015). Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments. Scientific Reports. 5(1). 11895–11895. 11 indexed citations

20.

Cai, Hao, Bo Liu, Lin Gui, & Min‐You Wu. (2012). Neighbor discovery algorithms in wireless networks using directional antennas. 767–772. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact